OLANZA

This brand name is authorized in Nigeria.

Active ingredients

The drug OLANZA contains one active pharmaceutical ingredient (API):

1
UNII N7U69T4SZR - OLANZAPINE
 

Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.

 
Read more about Olanzapine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-4255 Tablet Olanza-5 Tablet TAB 5 mg 2 x 24's (in PVC-Alu blisters) Tablet A white colored, circular, biconvex, film coated, tablet debossed “OL/5” on one side of the tablet OLANZA-5 TABLET OLANZAPINE 5MG each film coated tablet contains: olanzapine usp 5mg Excipients Q.S Colour: Titanium Dioxide A4-4255 Drugs Imported Products 2x14TABLETS Prescription Only Medicine (POM) 10/18/2022 NEW HEIGHTS PHARMACEUTICALS LTD, LAGOS LAGOS 8033205868 EBENEZER@NEWHEIGHTSPHARMA.COM AUROCHEM LABORATORIES (INDIA) PVT. LTD., 58, P.T.I.C.E. LTDPALGHAR-401 404. MAHARASHTRA, INDIA, India 9.19824E+11 INFO@AUROCHEMGROUP.COM 27/07/2023
A4-4256 Tablet Olanza-10 Tablet TAB 10 mg 2 x 14's (in AIu-PVC blisters) Tablet An orange colored, circular, biconvex, film coated tablet, embossed “OL /10” with lip type break line on one side of the tablet OLANZA-10 TABLET OLANZAPINE 10MG TABLET each film coated tablet contains: Olanzapine USP -10mg Excipients - Q.S. Colour: Sunset yellow A4-4256 Drugs Imported Products 2x14TABLETS Prescription Only Medicine (POM) 10/18/2022 NEW HEIGHTS PHARMACEUTICALS LTD, LAGOS LAGOS 8033205868 EBENEZER@NEWHEIGHTSPHARMA.COM AUROCHEM LABORATORIES (INDIA) PVT. LTD., 58, P.T.I.C.E. LTDPALGHAR-401 404. MAHARASHTRA, INDIA, India 9.19824E+11 INFO@AUROCHEMGROUP.COM 27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AH03 Olanzapine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-4255, A4-4256

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.